Biopsy-proven PCa: PSMA PET has shown promise for detecting nodal and distant metastasis of prostate carcinoma and is very useful for these indications in biochemically recurrent PCa (BCR). The gene discussed is FOLH1; the disease is posterior cortical atrophy.